Cardiac Biotech Solutions Inc. (CBSC)

OTCMKTS · Delayed Price · Currency is USD

0.0300

0.00 (0.00%)

Jul 20, 2026, 3:59 PM EST

Cardiac Biotech Solutions Financials Overview

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2018	FY 2017
Period Ending	Dec '18 Dec 31, 2018	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Revenue	0.05	0.04	0.03
Revenue Growth	-	11.11%	-
Gross Profit	0.03	0.02	0.02
Operating Income	-0.75	-1.13	-0.37
Net Income	-0.64	-1.13	-0.39
Earnings Per Share	-0.01	-0.02	-0.01
EPS Growth	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2018	FY 2017
Period Ending	Dec '18 Dec 31, 2018	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Net Cash (Debt)	0.01	0	0.01
Net Cash Growth	-	-62.63%	-
Net Cash Per Share	0.00	0.00	0.00
Cash & Investments	0.01	0	0.01

Cash Flow & CapEx

Fiscal Year	TTM	FY 2018	FY 2017
Period Ending	Dec '18 Dec 31, 2018	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Operating Cash Flow	-	-0.77	-0.06
Capital Expenditures	-	-0	-0
Free Cash Flow	-	-0.77	-0.06
Free Cash Flow Growth	-	-	-

Margins

Fiscal Year	TTM	FY 2018	FY 2017
Period Ending	Dec '18 Dec 31, 2018	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Gross Margin	54.34%	64.15%	49.32%
Operating Margin	-1486.00%	-3090.31%	-1122.17%
Pretax Margin	-1271.68%	-3090.31%	-1171.49%
Profit Margin	-1271.68%	-3090.31%	-1171.49%
FCF Margin	-	-2109.05%	-191.28%

Valuation

Fiscal Year	Current	FY 2018	FY 2017
Period Ending	Aug '26 Aug 5, 2026	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
PS Ratio	99.99	467.94	3032.81